# Barbara Pro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/barbara-pro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,440 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 63 |
| i10-index | 175 |
| Last Known Institution | Columbia University Irving Medical Center |
| OpenAlex ID | https://openalex.org/A5011181925 |
| Works | 420 |

## Researcher papers

- [Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project](https://scholariq.org/papers/follicular-lymphoma-international-prognostic-index-2-a-new-prognostic-index-for/)
- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [T-cell and Retrovirus Studies](https://scholariq.org/topics/t-cell-and-retrovirus-studies/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [Columbia University Irving Medical Center](https://scholariq.org/institutions/columbia-university-irving-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.